Ionis· @ionispharma · X·· 2026-07-06AI 评分42
AI 导读
今天我们宣布，针对天使综合征患者的在研 RNA 靶向药物全球 III 期 REVEAL 研究关键队列已完成入组。了解更多：https://bit.ly/4p7Hztq $IONS #AngelmanSyndrome #Angelman
正文
Today we announced that we’ve completed enrollment in the pivotal cohort of the global Phase 3 REVEAL study of our investigational RNA-targeted medicine for people living with Angelman syndrome. Read more: https://bit.ly/4p7Hztq
$IONS
#AngelmanSyndrome #Angelman
来源：Ionis · x.com